Rebelo Ana Rita, Bortolaia Valeria, Leekitcharoenphon Pimlapas, Hansen Dennis Schrøder, Nielsen Hans Linde, Ellermann-Eriksen Svend, Kemp Michael, Røder Bent Løwe, Frimodt-Møller Niels, Søndergaard Turid Snekloth, Coia John Eugenio, Østergaard Claus, Westh Henrik, Aarestrup Frank M
National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Front Microbiol. 2022 Jun 10;13:804627. doi: 10.3389/fmicb.2022.804627. eCollection 2022.
Antimicrobial susceptibility testing (AST) should be fast and accurate, leading to proper interventions and therapeutic success. Clinical microbiology laboratories rely on phenotypic methods, but the continuous improvement and decrease in the cost of whole-genome sequencing (WGS) technologies make them an attractive alternative. Studies evaluating the performance of WGS-based prediction of antimicrobial resistance (AMR) for selected bacterial species have shown promising results. There are, however, significant gaps in the literature evaluating the applicability of WGS as a diagnostics method in real-life clinical settings against the range of bacterial pathogens experienced there. Thus, we compared standard phenotypic AST results with WGS-based predictions of AMR profiles in bacterial isolates without preselection of defined species, to evaluate the applicability of WGS as a diagnostics method in clinical settings. We collected all bacterial isolates processed by all Danish Clinical Microbiology Laboratories in 1 day. We randomly selected 500 isolates without any preselection of species. We performed AST through standard broth microdilution (BMD) for 488 isolates ( = 6,487 phenotypic AST results) and compared results with antibiograms obtained through WGS (Illumina NextSeq) followed by bioinformatics analyses using ResFinder 4.0 ( = 5,229 comparisons). A higher proportion of AMR was observed for Gram-negative bacteria (10.9%) than for Gram-positive bacteria (6.1%). Comparison of BMD with WGS data yielded a concordance of 91.7%, with discordant results mainly due to phenotypically susceptible isolates harboring genetic AMR determinants. These cases correspond to 6.2% of all isolate-antimicrobial combinations analyzed and to 6.8% of all phenotypically susceptible combinations. We detected fewer cases of phenotypically resistant isolates without any known genetic resistance mechanism, particularly 2.1% of all combinations analyzed, which corresponded to 26.4% of all detected phenotypic resistances. Most discordances were observed for specific combinations of species-antimicrobial: macrolides and tetracycline in streptococci, ciprofloxacin and β-lactams in combination with β-lactamase inhibitors in , and most antimicrobials in . WGS has the potential to be used for surveillance and routine clinical microbiology. However, in clinical microbiology settings and especially for certain species and antimicrobial agent combinations, further developments in AMR gene databases are needed to ensure higher concordance between predictions and expected phenotypic AMR profiles.
抗菌药物敏感性试验(AST)应快速且准确,以实现恰当的干预并取得治疗成功。临床微生物学实验室依赖表型方法,但全基因组测序(WGS)技术的不断改进及成本降低使其成为颇具吸引力的替代方法。评估基于WGS预测选定细菌物种抗菌药物耐药性(AMR)性能的研究已显示出有前景的结果。然而,在评估WGS作为一种诊断方法在实际临床环境中针对所遇到的各类细菌病原体的适用性方面,文献中存在显著空白。因此,我们将标准表型AST结果与基于WGS对未预先选择特定物种的细菌分离株AMR谱的预测进行比较,以评估WGS作为一种诊断方法在临床环境中的适用性。我们收集了丹麦所有临床微生物学实验室在一天内处理的所有细菌分离株。我们随机选择了500株未进行任何物种预先选择的分离株。我们通过标准肉汤微量稀释法(BMD)对488株分离株进行了AST试验(共获得6487个表型AST结果),并将结果与通过WGS(Illumina NextSeq)获得的抗菌谱进行比较,随后使用ResFinder 4.0进行生物信息学分析(共进行5229次比较)。观察到革兰氏阴性菌的AMR比例(10.9%)高于革兰氏阳性菌(6.1%)。BMD结果与WGS数据的一致性为91.7%,不一致的结果主要是由于表型敏感的分离株携带遗传AMR决定因素。这些病例占所有分析的分离株 - 抗菌药物组合的6.2%,占所有表型敏感组合的6.8%。我们检测到表型耐药但无任何已知遗传耐药机制的病例较少,特别是占所有分析组合的2.1%,这相当于所有检测到的表型耐药情况的26.4%。大多数不一致情况出现在特定的物种 - 抗菌药物组合中:链球菌中的大环内酯类和四环素、大肠埃希菌中与β - 内酰胺酶抑制剂联合使用的环丙沙星和β - 内酰胺类,以及肺炎克雷伯菌中的大多数抗菌药物。WGS有潜力用于监测和常规临床微生物学。然而,在临床微生物学环境中,尤其是对于某些物种和抗菌药物组合,需要进一步开发AMR基因数据库,以确保预测结果与预期的表型AMR谱之间具有更高的一致性。